Gene editing for plants could feed the world

New tech might avoid public unease with GMOs

THE NEW ENGLAND life sciences industry has produced an explosion of therapies for small patient populations with rare diseases.  Last year, fully half of newly approved drugs were for these smaller populations. While emerging biotech therapies provide hope for small clusters of human patients with rare diseases, when deployed to the agricultural sector, biotech advances(...)

Read More »